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ABSTRACT
Skin cancer is one of the most common types of cancer around the world. For this reason, over the
past years, different approaches have been proposed to assist detect it. Nonetheless, most of them are
based only on dermoscopy images and do not take into account the patient clinical information. In
this work, first, we present a new dataset that contains clinical images, acquired from smartphones,
and patient clinical information of the skin lesions. Next, we introduce a straightforward approach to
combine the clinical data and the images using different well-known deep learning models. These
models are applied to the presented dataset using only the images and combining them with the
patient clinical information. We present a comprehensive study to show the impact of the clinical
data on the final predictions. The results obtained by combining both sets of information show a
general improvement of around 7% in the balanced accuracy for all models. In addition, the statistical
test indicates significant differences between the models with and without considering both data.
The improvement achieved shows the potential of using patient clinical information in skin cancer
detection and indicates that this piece of information is important to leverage skin cancer detection
systems.
Keywords Skin cancer detection · deep learning · data aggregation · clinical images · clinical information
1 Introduction
The skin cancer occurs when skin cells are damaged, for example, by overexposure to ultraviolet (UV) radiation from
the sun [1]. Although its incidence data are not required to be reported by most cancer registries [2], the World Health
Organization (WHO) estimates that one in every three cancers diagnosed is a skin cancer [3]. In countries such as USA,
Canada, and Australia, the number of people diagnosed with skin cancer has been increasing at a fairly constant rate
over the past decades [1, 4, 5]. In Brazil, according to the Brazilian Cancer Institute (INCA), the skin cancer accounts
for 33% of all cancer diagnoses in the country. This is the highest diagnosis rate among all kind of cancer and for
2018-2019 it is expected 180 thousand new cases in the whole country [6].
There are three main types of skin cancer: basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma.
The melanoma is the rarest type of skin cancer, however, due to the high level of metastasis1, it is the most lethal one.
On the other hand, BCC and SCC, which is known as non-melanoma skin cancer (NMSC), represent the major skin
cancer occurrence. As they rarely metastasize, they have low lethality risk [1]. In order to diagnose the skin cancer,
dermatologists screen the suspicious skin lesion using their experience to diagnose it. Moreover, they also take into
account clinical information such as patient’s age, wherein the lesion is located, if the lesion bleeds, among others
1when damaged cells invade other parts of the body via blood vessels and lymph vessels
ar
X
iv
:1
90
9.
12
91
2v
1 
 [e
es
s.I
V]
  1
6 S
ep
 20
19
A PREPRINT - AUGUST 10, 2019
[7, 8]. These pieces of information are very important for dermatologists, nevertheless, differentiate a skin lesion to
skin cancer is still challenging. In this sense, to increase the diagnosis reliability, dermatologists use the dermatoscope,
a medical instrument that allows the visualization of the subsurface structures of the skin revealing lesion details in
colors and textures [9].
Kittler et al. [10] and Sinz et al. [11] have shown the positive effect of the dermoscopy technique in the diagnostic
accuracy. Nonetheless, they also conclude that this accuracy significantly depends on the dermatologist experience
degree, i.e., less experienced examiners do not present improvement using the dermatoscope. This reason alone justifies
the need for a computer-aided diagnosis (CAD) systems for skin cancer. Nonetheless, in emerging countries, such as
Brazil, there is a strong lack of dermatologists and dermatoscopes in most of its countryside cities. Thereby, a system
to assist doctors in the skin cancer diagnosis that does not depend on dermoscopy images is very desired. However,
designing such a system is a challenging task.
Over the past decades, different computer-aided diagnosis (CAD) systems have been proposed to tackle skin cancer
detection. Pioneers works, such as [12], [13] and [14], reported the use of low level handcrafted features to differentiate
melanomas and NMSC. Later, different computational approaches have been developed based on ABCD(E) rule, pattern
analysis and 7-point checklist, which are common methods used by the dermatologist in order to diagnose the skin
cancer [15, 16]. These approaches mostly use traditional computer vision algorithms to extract various features, such as
shape, colour, and texture [17, 18, 19, 20, 21], to fed a classifier, for example, a support vector machine (SVM) [22, 23].
Two weakness may be found in these approaches. First, the ABCD(E) rule and the 7-point checklist were designed
only for pigmented lesions, which means they cannot be used to diagnose BCC nor SCC, for example. Second, the
handcrafted features extracted by these methods have limited generalization capability [24].
Recently, deep learning models have been achieving remarkable results in different medical image analysis tasks [25, 24].
In particular, convolutional neural networks (CNN) have become the standard approach to handle this kind of problem
[26, 27]. Several deep learning models have been proposed for skin cancer detection task. Yu et al. [24] presented a
very deep CNN and a set of schemes to learn under limited training data. Esteva et al. [28] used a pre-trained GoogleNet
CNN architecture [29] to train more than 120 thousand images and achieved a dermatologist-level diagnostic. Haenssle
et al. [30] and Brinker et al. [31] also used a deep learning models to compare their performance to dermatologists. In
both studies, the models have shown competitive or outperformed the dermatologists. Other efforts have been made
using deep learning to detect skin cancer, such as ensemble of models [32, 33], feature aggregation of different models
[34], among others [35, 36, 37, 38]. Most of these works are based on dermoscopy images, mainly for two reasons: 1)
there is an open well-known dataset provided by the International Skin Imaging Collaboration (ISIC) [39]; 2) obtaining
a dataset of clinical images of skin cancer is a hard task. Developing CAD systems to work with dermoscopic images is
important, however, as stated before, emerging countries do not have dermatoscopes available in most of their regions.
Thereby, these systems are not feasible for those places. Furthermore, there is a trend in developing CAD systems
embedded in smartphones, either for general users or to assist doctors [40, 41]. Indeed, the use of smartphones to assist
in skin cancer detection seems to be very feasible. However, it is necessary to have clinical images rather dermoscopy
ones.
Beyond the lack of CAD systems using clinical images, most of these systems do not take into account the patient
clinical information, which is an important clue towards a more accurate diagnosis [8]. In fact, the dermatologists
do not trust only on the image screening, they also use the patient clinical information in order to provide a more
reliable diagnostic. In this sense, Brinker et al. [42] presented a review for deep learning models applied to skin cancer
detection and concluded that an improvement in classification quality could be achieved by adding clinical data in the
classification process. Based on this idea, Kharazmi et al. [43] proposed a deep learning approach to detect BCC using
dermoscopic images and five patients clinical information. The results using the clinical data present an improvement,
however, they did not analysis how much it affect in the classification. Moreover, they are able to recognize only one
type of skin cancer and do not consider clinical images.
In this work, we present a study to analyze the impact of clinical patient information on deep learning models applied
to skin cancer detection. In addition, we present a new skin cancer dataset composed by clinical images and patient
information and an approach to aggregate the skin cancer images with their respective clinical information. The main
contributions of this work are summarized as follows:
• In partnership with the Dermatological Assistance Program (PAD) at the Federal University of Espírito Santo
(UFES), which is a nonprofit organization that provides skin lesion treatment for low-income people in Brazil,
we developed an smartphone application to collect skin lesions images and patient clinical information. From
this software, we built a new dataset composed of clinical images and patient clinical information. Since the
process of collection of this kind of data is hard, we intend to make this dataset available for research purpose.
As far as we know, there is no public skin cancer dataset that contains clinical image and patient clinical
information available in the literature.
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• We use well-known deep learning models to develop an approach to aggregate the clinical images and the
patients clinical information. This approach introduces a straightforward mechanism to control the contribution
of each source of data.
• We present a comprehensive study to show the impact of the patients clinical data in the skin cancer detection.
We analyze the model results with and without using the patient clinical information in order to show the
advantages of use this data and how it impacts in the final diagnosis.
The rest of this paper is organized as follows: in section 2 we present the methods and data; in section 3 is presented
experiments and results obtained; in section 4 we draw some conclusions.
2 Material and methods
In this section, first, we describe the details of the collected dataset. Next, we present a data exploration analysis in
order to understand the patient clinical feature patterns. In the following, we describe the models we use in the work
and our strategy to combine both the clinical images and the patient clinical information.
2.1 Dataset
In order to acquire clinical images and the patients clinical data, we developed a smartphone-based application to be
used by doctors and medical students from the Dermatological Assistant Program (PAD) at the Federal University of
Espirito Santo (UFES). Through this application, they attach one or more images of the skin lesion2 as well as the
clinical information related to it. In this sense, each sample in this dataset has a clinical diagnosis, an image and eight
clinical information: the patient’s age, the part of the body where the lesion is located, if the lesion itches, bleeds or has
bled, hurts, has recently increased, has changed its pattern and if it has an elevation. All these pieces of information are
based on the same questions that the PAD’s dermatologists ask the patients during the appointment. The application
also allows tracking all patient’s lesion to follow its evolution throughout the time. Evolution is an important feature and
it stands for the E in the ABCD(E) rule. Despite its importance, it will take some years until this information become
available, since the lesion may take some time to grow up and the patient needs to return to be assisted. Thereby,
when the dermatologists ask the patient if the lesion has increased and if it has changed its pattern, they are trying to
obtain information about the lesion’s evolution. Nonetheless, as these features are obtained by asking the patients, it is
important to note they may describe such information with some subjectivity and imprecision. For this reason, this kind
of information must be used to support the diagnosis. The main information is still coming from the screening, i.e., the
image.
Regarding the region of the body where the skin lesion is located, there are more than 120 anatomical regions used by
the dermatologists. Based on the PAD’s dermatologists experience, we grouped all the regions in 15 macro regions
that are more frequent and have more potential to arise a skin lesion, they are: face, scalp, nose, lips, ears, neck, chest,
abdomen, back, arm, forearm, hand, thigh, shin and foot. As skin lesions have a preference for some regions of the
body [7, 8], it is an important feature to considerate.
We have been collecting this dataset for one year and a half. There are more than fifty types of skin lesions that were
collected by our software. However, most of them are rare and contain only a few samples, which makes them very
hard to be used in deep learning models. Thereby, for this work, we decided to use the eight most common skin lesion
diagnosed at PAD, which are: Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), Actinic Keratosis
(ACK), Seborrheic Keratosis (SEK), Bowen’s disease (BOD), Lentigo Maligna (LEM), Melanoma (MEL) and Nevus
(NEV). As the Bowen’s disease and Lentigo Maligna are considered SCC in situ and MEL in situ [7], respectively, we
clustered them together, which results in six skin lesions in the dataset. In Table 1 is detailed the number of samples for
each type of skin lesion present in the dataset. It is important to note this dataset has three skin cancers, BCC, SCC and
MEL, and three skin diseases, which may become cancer if not treated, ACK, SEK and NEV. As stated before, the
MEL is the most dangerous but rarest, while SCC and BCC are the most common type of skin cancer. The frequency of
these samples in the dataset is according to this statement, which makes the PAD dataset imbalanced. In fact, having
imbalanced labels is a peculiarity of skin cancer datasets. For instance, the same issue happens with the ISIC dataset
[39] and we need to find solutions to tackle it.
In Figure 1 is depicted one example for each type of skin lesion present in our dataset. We may note that PAD dataset
has three pigmented skin lesions, MEL, NEV and SEK and three non-pigmented ones BCC, SCC and ACK. Lastly, this
2In general, we name wounds, moles or spots on the skin as skin lesions. After the diagnosis, the skin cancers will be named as
so and the remaining ones will be called by skin diseases
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Table 1: The number of samples for each type of diagnosis
Clinical diagnosis N◦ of images
Actinic Keratosis (ACK) 543
Basal Cell Carcinoma (BCC) 442
Melanoma (MEL) 67
Nevus (NEV) 196
Squamous Cell Carcinoma (SCC) 149
Seborrheic Keratosis (SEK) 215
Total 1612
(a) BCC (b) SCC (c) ACK
(d) MEL (e) NEV (f) SEK
Figure 1: Samples of each type of skin lesion from PAD dataset. SCC, BCC and MEL are skin cancers and NEV, SEK
and ACK are skin disease
dataset is available upon request. To the best our knowledge, this is the first public skin cancer dataset composed by
images obtained from smartphones and their respectively clinical information.
2.2 Clinical features analysis
In order to better understand the influence of the clinical information in the skin cancer detection, we performed a data
exploration analysis using the patients clinical features. In Figure 2 is shown the plots of the main findings about this
set of data. In the left, we observe the plots related to bleeding and pain. As we can see, they are useful to differentiate
the pigmented (NEV, MEL, and SEK) from the non-pigmented lesions. Further, we observe that the ACK usually does
not hurt. In fact, only SCC and BCC are usually painful lesions. In right side of the Figure 2, we can see a bar plot for
itching and a box plot for the patient’s age. For itching, again we may observe that in general, the pigmented lesions
itch more than the non-pigmented ones. Regarding the patient’s age box plot, we can note that the median age for NEV
is lower than MEL and SEK. Thereby, this feature is useful to differentiate these lesions. For the non-pigmented lesions,
the median for the ACK is slightly lower than SCC and BCC, which lay down in almost the same range. In the center,
is presented the plot for the region of the body frequency. Indeed, the lesion present preference for some regions. For
instance, The ACK appears more in the forearm, NEV in the back and SCC, BCC, MEL and SEK in the face. We also
analyzed the remained collected features. In summary, we observe that MEL and ACK do not have elevation in the skin,
which distinguishes them from the other ones; only MEL usually changes its pattern, which is an important feature to
detect this type o cancer; and lastly, all lesions, except ACK, usually grow up, but it is hard to find a pattern for this
feature.
Based on the presented analysis, we draw the following conclusions:
• It is expected that these features improve the model performance for pigmented and non-pigmented lesions
detection.
• There are punctual features, such as change in the lesion pattern and elevation, that is important for MEL
detection.
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Figure 2: Exploratory analysis of the patients clinical features
• In general, SCC and BCC share the same clinical features values. Both bleed, hurt, itch, have elevation, occur
in the same age range and have the same preferred region. Thus, it is expected these features do not help to
much for these labels.
2.3 Convolutional Neural Networks
The Convolutional Neural Network (CNN) is a special type of a Neural Network (NN) that was developed to learn visual
features from images. Nowadays, it is the most successful deep learning methodology to handle the image classification
task [44]. The standard CNN is basically composed of three layers: convolutional, pooling and fully-connected layers.
The convolutional layer is the most important and performs the most part of the computation. It consists of kernels,
which is composed of weights, that learn visual features from the input images. Each kernel is convolved across the
whole image and produces a feature map, which is the output of this layer. The pooling layer is used basically to reduce
the feature map size. As a result, it also reduces the number of parameters to be trained in the layers that comes after it,
helps to control overfitting and, along with a non-linear activation filter, it adds non-linearity to the network. Lastly, the
fully-connected layer is a traditional NN that is connected to the last feature map provided by the previous layer. In
summary, the composition of convolutional and pooling layers is known as feature extractor, and the fully-connected
layer is the classifier.
Different CNN architectures have been used to tackle skin cancer detection. Successful results have been reported by
Steva et al. [28] using GoogleNet [45], Yu et al. [34] with ResNet [46] and Menegola et al. [47] using VGGNet [48].
Nonetheless, for medical tasks, obtaining a large amount of data to train a CNN is quite challenging. To overcome this
issue, all these works used transfer learning, a well-known technique where a model trained for a given source task is
partially reused for a new target task [47]. Thereby, the models were initialized using the weights from the ImageNet
dataset [49] and then fine-tuned using their own dataset.
In this work, our goal is to investigate the impact of clinical information on skin cancer detection. Thus, we decided to
use the CNNs mentioned before, i.e, GoogleNet, ResNet50/101 and VGGNet13, but we also included the MobileNet
[50]. Each network is briefly described in the following:
• GoogleNet: this network introduced the inception module, which is an approach based on several very small
convolutions that reduce the number of parameters to be optimized in the training phase [45]. It is composed
of 9 stacked inception modules that lead to 22 convolutional layers. Also, among these layers, it is performed
pooling layers, batch normalization and non-linear activations with ReLU. The feature extractor outputs 1024
image features for the classifier.
• VGGNet-13/19-bn: this CNN architecture consists of 13/19 layers composed of small convolutional filters
[48]. It also includes batch normalization, non-linear activations with ReLU and pooling layers after two or
three convolutions. The feature extractor outputs 25088 image features for the classifier.
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Figure 3: Illustration of the methodology used to combine the image features with the patient clinical information. First,
the image features are extracted by the CNN feature extractor. Next, these features are reduced by the feature reducer
block and combined with the clinical data. Finally, the combined features are inputted to the classifier that outputs the
final diagnostic.
• ResNet-50/101: this network architecture reformulates the layers as learning residual functions with reference
to the layer inputs, instead of learning unreferenced functions [46]. It is achieved using an approach that skip
connections of some layers and applying batch normalization along with non-linearities (ReLU). In this work,
we use two ResNet version, one containing 49 convolutional layers and another one containing 100. Both
feature extractors return 2048 image features for the classifier.
• MobileNet: this architecture is based on depth-wise separable convolutions, which is a depth-wise convolution
followed by point-wise convolution. This strategy significantly reduces the number of parameters when
compared to the network with normal convolutions with the same depth [50]. It also introduces two hyper-
parameters to control the model’s size. In this work, we use the MobileNet with its full size, which lead to 22
convolutional layers. Similar to the others, it also use ReLU and batch normalization. The feature extractor
returns 1024 image features for the classifier.
For all these networks, we kept the feature extractor layers and modified the classifier to include the patients clinical
information. This is better described in the next subsection.
2.4 Proposed approach to combine clinical images and clinical information
In order to consider the patient clinical information into the skin cancer classification, we need to provide a way to
combine it with the clinical images. The most common approach to aggregate external features with images is to
concatenate the features extracted from the images with the extra ones [51, 52]. Nonetheless, the issue to use an
approach similar to this one for our task is that there are much more image features than patient information, which
means we need a feature reducer. In this sense, we propose an approach that uses a NN to reduce the image features
based on a mechanism to control the influence of each set of features, i.e., the image features and the patient clinical
information.
In Figure 3 is illustrated the main concept of the proposed aggregation. As we can observe, the CNN’s feature extractor
is kept, we do not change anything in these layers. Next, the last feature map is flattened and outputted as image
features. Next, these features are forwarded to the feature reducer block. This block is composed by a traditional
neural network that is trained to work as a non-linear feature reducer. The architecture of the reducer network varies
according to the CNN architecture. Further, the number of features outputted by this block is based on the combination
factor (cf ), which is a mechanism to control how much nodes/image features will be used in the next block. Using
this mechanism, we control how much information each source contribute to the concatenation and, consequently, to
the classifier. Considering Nimg and Ncli the number of features that comes from the images and clinical information,
respectively, to compute the total number of features T to be sent to the classifier, we need to combine both set of
features according to the cf :
T = dcfNimg + (1− cf )Nclie (1)
where 0 ≤ cf ≤ 1 and de is the ceil operator. As we can note from equation 1, the combination factor cf controls the
amount of feature provided by the image and the clinical information. Nonetheless, in this work, we do not intend to
reduce the amount of clinical information since it is already small compared to the image features. Thereby, we set
T = Ncli(1−cf ) , which Ncli is the current value of the clinical features, and we compute Nimg as follows:
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Figure 4: Difference between the original images (left) and the images after the color constancy preprocessing (right)
Nimg =
⌈
Ncli
1− cf −Ncli
⌉
(2)
Based on equation 2, we are keeping the same value of clinical features and varying the value of image features. In
section 3.3 we present a sensitivity analysis regarding the combination factor.
Since we determined the contribution of each source, both set of features are concatenated and sent to the classifier, as
shown in Figure 3. The classifier is another neural network that outputs the probability of a lesion for each diagnostic.
The entire model presented in this section is trained by an end-to-end backpropagation. This is the main reason we
decide to a neural network as the reducer block, i.e., it can be optimized along with the CNN feature extractor and
classifier by including it in the backpropagation computation. We could choose a methodology such as PCA [53],
however, beyond the fact it is linear, the proposed approach is faster and simpler, since the backpropagation is already
used to train the image feature extractor blocks. Since the computational cost to train a CNN is high, designing
approaches that take advantage of its training process is very desired.
3 Experiments and results
In this section, we present the experiments carried out using the presented dataset and the models described in the
previous section. First, we describe how we prepared the dataset, next we present the common setup for the experiments,
a sensitivity analysis regarding the combination factor and then the comparison between the models using only the
clinical images and combining them with the patient clinical features.
3.1 Data preparation
The dataset introduced in section 2.1 presents similar characteristics of any medical dataset. As we may observe in
Table 1, the amount of data is not large and the dataset is imbalanced. In addition, as it is acquired using smartphones
camera, it presents fewer details of the skin lesion, when compared to dermoscopy images, and the camera resolution
and illumination affect the images’ quality. Vasconceloas and Vasconcelos [54] presented a work in which they discuss
approaches to handle these type of issues in skin cancer datasets. According to them, we can tackle these issues with
transfer learning, up/downsampling, data augmentation, and by using an ensemble of models. In addition, Barata
et al. [20] have shown the benefits of using color constancy algorithms for skin cancer detection. Following their
recommendations, we applied the shades of gray method [55] for all images before the trained phase. The difference
between the clinical images with and without the color constancy preprocessing can be seen in the samples depicted in
Figure 4.
As described in section 2.3, we use transfer learning for all models. In addition, we applied a strong data augmentation
using common image processing operations [56]. We adjust brightness, contrast, saturation and hue, and we apply
horizontal and vertical rotations, translations, re-scale and shear. In addition, we include Gaussian noise and applied
blur, since there are some blurred images in the dataset. Lastly, to tackle the labels imbalanced issue, we use a weight
loss function based on the labels frequency. Thereby, the weight for a given label i is computed as follow:
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wi =
N
ni
(3)
where N is the total number of samples in the dataset and ni is the number of samples of label i. We also tried to use
upsampling to equalize the number of samples for each class, but it created a high bias in the MEL label, which resulted
in a lower performance compared to the weight loss function approach.
Regarding to the clinical features, we applied the one-hot strategy to encode the features represented by strings, i.e.,
all of them, except the age, which is a integer. Thus, instead of 8 values, after the one-hot encode, the total number
of clinical features (Ncli) is an array of 28 values. As described in equation 2, the size of this array will be used to
compute Nimg .
3.2 Experiments setup
In order to verify the impact of the patient clinical information, we carried out the experiments considering two
scenarios:
• Scenario 1: the models consider only the clinical images
• Scenario 2: the models combine the clinical images and the patient clinical features
As stated before, for each model, we use its original image feature extractor block. Thus, this block is the same for both
scenarios. For scenario 2, we need to define the reducer block described in section 2.4. For all models, except VGGnet,
the reducer block is composed by one layer whereas the number of neurons is defined by the combination factor. As the
number of image features outputted by VGGnet is more than 25 thousand, the only difference for this model is that we
add an intermediate layer containing 1024 neurons. For scenario 1, we tested all models with and without the feature
reducer block. Nonetheless, both approaches present the same results. Thereby, for simplicity, we keep the reducer
block for this scenario. Also, the reducer block uses the ReLU activation function and dropout rate equal to 0.5.
For both scenarios, the classifiers input neurons are defined by the reducer block and the output for the number of label,
which is 6. All models were trained using two phases. First, we freeze the convolutional layers and train only the fully
connected one. Next, we reduce the training rate and fine-tune the entire model. For all models, we use the Adam
optimizer with learning rate equals 0.0001 for the first phase and 0.00001 for fine-tune. As a loss function we use the
weight cross entropy considering the weights computed as described in equation 3. The first and second phases are
trained for 50 and 100 epochs, respectively. We reduce the learning rate by a rate of 0.1 if the model does not improve
for 10 consecutive epochs. We also use early stop if the model does not improve for 15 consecutive epochs. For a fair
comparison, both experiments, with and without clinical features, were carried out in the same way and using the same
hyperparameters. All procedures were implemented using PyTorch and performed on Nvidia Titan X and RTX 2080 ti.
The code is available upon request.
For the following experiments, we use a 5-fold cross validation and present the average and standard deviation for the
following metrics: accuracy (ACC), balanced accuracy (BACC), weighted precision (P), weighted recall (R), weighted
F1 score (F1) and area under the curve (AUC). Lastly, in order to compare the obtained results by the experiments,
we perform the non-parametric Friedman test following by the Wilcoxon test (if applicable), using pvalue = 0.05 and
pvalue = 0.01 respectively [57].
3.3 Experiment 1: sensitivity analysis of the combination factor
In this section, we aim to evaluate the contribution of each source of features in the skin cancer detection. As described
in the previous sections, the number of clinical feature (Ncli) is 28. To vary only the number of image features (Nimg),
we keep Ncli and vary cf from 0.5 to 0.9. In Table 2 is described the the amount of features for each source according
to cf . Considering cf = 0.7, it means the reducer block will output 66 features from the image and these features will
be concatenated with the 28 clinical features. Thus, 94 features are sent to the classifiers, which 70% come from the
images and 30% from clinical information. This is how cf controls the amount of contribution from each source.
In order to test each value of cf presented in Table 2, we applied the ResNet-50 for each folder of our dataset. The
result for each metric is detailed in Table 3. The Friedman test returned pvalue < 0.05, which means we need to apply
the pairwise comparison. Thereby, we applied the Wilcoxon test, that pointed out many differences among the pairs.
Based on the test assessment and on the results presented in Table 3, we conclude that the best value for cf is either 0.8
or 0.7. There is no statistical difference between this pair. On the other hand, for 0.5 and 0.9, the results are slightly
worse, which is also identified by the test.
8
A PREPRINT - AUGUST 10, 2019
Table 2: The number of features from both sources varying cf
cf Nimg Ncli Total
0.5 28 28 56
0.6 42 28 70
0.7 66 28 94
0.8 112 28 140
0.9 252 28 280
Table 3: The ResNet-50 performance for each value of cf
cf ACC BACC P R F1 AUC
0.5 0.759± 0.025 0.718± 0.032 0.776± 0.021 0.758± 0.028 0.764± 0.024 0.948± 0.010
0.6 0.773± 0.026 0.739± 0.015 0.790± 0.022 0.774± 0.023 0.780± 0.023 0.948± 0.005
0.7 0.763± 0.032 0.733± 0.022 0.788± 0.016 0.762± 0.029 0.766± 0.032 0.955± 0.004
0.8 0.788± 0.025 0.750± 0.033 0.800± 0.028 0.788± 0.025 0.790± 0.027 0.958± 0.007
0.9 0.736± 0.036 0.710± 0.035 0.740± 0.046 0.726± 0.031 0.734± 0.021 0.949± 0.013
Based on the presented analysis, we decided to use cf = 0.8 for the next experiment. As discussed before, the clinical
features should be used as a support source of information. The main source is still the clinical images. This assumption
is in accordance with the results obtained in this section.
3.4 Experiment 2: the impact of the clinical features
In this section, our main goal is to compare the performance of the models for both scenarios described in section
3.2. To do so, according to our previous analysis, we set cf = 0.8 and apply all models described in section 2.3 to the
presented dataset. In Table 4 and 5 are presented the results considering the 5-folders for scenario 1 and 2, respectively.
Table 4: The result for all models in scenario 1, i.e, considering only the clinical images
Model ACC BACC P R F1 AUC
ResNet-50 0.671± 0.041 0.649± 0.047 0.720± 0.041 0.670± 0.041 0.678± 0.037 0.927± 0.017
ResNet101 0.691± 0.039 0.651± 0.035 0.736± 0.028 0.692± 0.039 0.700± 0.042 0.938± 0.008
GoogleNet 0.704± 0.024 0.652± 0.019 0.714± 0.024 0.702± 0.025 0.706± 0.023 0.927± 0.011
MobileNet 0.691± 0.024 0.663± 0.027 0.720± 0.014 0.690± 0.025 0.698± 0.018 0.932± 0.008
VGGNet-13 0.707± 0.028 0.658± 0.045 0.734± 0.029 0.708± 0.028 0.710± 0.029 0.932± 0.010
VGGNet-19 0.679± 0.020 0.628± 0.012 0.696± 0.020 0.678± 0.019 0.680± 0.021 0.919± 0.009
AVG 0.690± 0.029 0.650± 0.031 0.720± 0.026 0.690± 0.030 0.695± 0.028 0.929± 0.011
As we can note from both tables, there is a notable improvement for all metrics from scenario 1 to scenario 2. In
general, the clinical features impacted positively in all models. In terms of balanced accuracy, the average model was
improved in almost 7%. The overall improvement considering all metrics is also around 7%. Although the improvement
is notable, we also applied the statistical test for this experiment. As expected, the test shows that all models from
scenario 2 are statistical different than the ones from scenario 1. Therefore, based on the test and the results present in
the tables, we conclude that for this experiment, the best option is including the clinical features.
Observing only the results for scenario 2 in Table 5, in terms of balanced accuracy, we note all models with almost the
same performance, except ResNet-50, which is around 4% above compared to the rest of the models. In order to better
investigate the influence of the clinical feature in this model, in Figure 5 is depicted the ResNet-50 confusion matrix
and ROC curve for each scenario 3. In general, it is possible to note an improvement for all labels. However, the model
is still confusing SCC and BCC quite often. This results is in accordance with the analysis provided in section 2.2, in
which we show that both lesions share almost the same value of features. In fact, even dermatologists get confusing
regarding these two lesions. It is very challenging to differentiate them even using a dermatocospe since they are very
similar, as shown in Figures 1(a) and 1(b). Nonetheless, confusing SCC and BCC is not quite a problem since both are
skin cancer and need to be removed and sent to biopsy. The real problem is confusing them with ACK, which is just a
minor skin disease that is treated without a surgical process, for example. For this lesion, the model does a fair job,
even though there is still room for improvement.
3As we would have 12 confusion matrices and 12 ROC curves, we decided to present a thorough analysis only for the best model.
However, the remaining results are quite similar.
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(a) Scenario 1 (b) Scenario 2
(c) Scenario 1 (d) Scenario 2
Figure 5: The confusion matrices (above) and ROC curves (below) for ResNet-50 considering for both scenarios
Figure 6: The probability distribution generated by the ResNet-50 for each lesion in both scenarios
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Table 5: The result for all models in scenario 2, i.e, considering both the clinical features and images
Model ACC BACC P R F1 AUC
ResNet-50 0.788± 0.025 0.750± 0.033 0.800± 0.028 0.788± 0.025 0.790± 0.027 0.958± 0.007
ResNet101 0.757± 0.021 0.711± 0.019 0.784± 0.021 0.756± 0.021 0.766± 0.022 0.953± 0.003
GoogleNet 0.779± 0.011 0.714± 0.028 0.780± 0.011 0.780± 0.009 0.778± 0.007 0.948± 0.008
MobileNet 0.762± 0.040 0.717± 0.020 0.774± 0.031 0.762± 0.042 0.762± 0.037 0.948± 0.013
VGGNet-13 0.746± 0.027 0.704± 0.007 0.758± 0.013 0.748± 0.029 0.744± 0.023 0.937± 0.011
VGGNet-19 0.750± 0.013 0.709± 0.023 0.776± 0.005 0.748± 0.013 0.756± 0.010 0.946± 0.004
AVG 0.764± 0.023 0.718± 0.022 0.779± 0.018 0.764± 0.023 0.766± 0.021 0.948± 0.008
To conclude this experiment, we analyze the effect of the clinical features in the probability distribution generated by
the ResNet-50 model. In Figure 6 is depicted the distributions obtained by the same model for each lesion in both
scenarios. As we may see, the distributions for ACK, MEL, NEV and SEK are improved from scenario 1 to scenario 2
by increasing the own label probability and decrease the remaining ones. On the other hand, the distributions for SCC
and BCC are almost the same, which is in accordance with the previous results. In overall, the results presented in this
section confirm the hypothesis raised by Briker et al. [42] that clinical features is an important piece of information to
be used in deep learning models in order to improve the skin cancer detection. Nonetheless, we show it is not effective
for all kind of lesions, which is the case of SCC and BCC detection.
4 Conclusion
In this paper, we presented a study to analyze the impact of the patient clinical information on the skin cancer detection
using deep learning models. First, we introduced a new dataset containing clinical images, acquired from smartphones
cameras, and patients clinical information. Next, we presented a straightforward approach to combine the image
and clinical features using convolutional neural networks. We implemented this approach for different CNN models
and applied them for the presented dataset. The results indicated that the clinical features provided a substantial
improvement for all investigated models in this work. It was possible to note that the clinical features are important
pieces of information that may help to overcome the lack of large amount of data. Nonetheless, the clinical features used
are not helpful for all kind of lesions. As we discussed, they were not able to improve the classification of SCC/BCC
lesions, since its features are quite similar. In general, this work showed the importance of clinical features in skin
cancer detection and confirms the hypothesis that patient clinical information is helpful for this task. As a future work,
we intend to improve the aggregation approach and include a hierarchical classification in order to improve the SCC
and BCC detection. In addition, we are already working on the inclusion of more clinical features and more images in
our dataset.
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